531889 Sigma-AldrichSTING Agonist, 2ʹ3ʹ-cGAMP - CAS 1441190-66-4 - Calbiochem
Recommended Products
Overview
Replacement Information |
---|
Key Specifications Table
CAS # | Empirical Formula |
---|---|
1441190-66-4 | C₂₀H₂₄N₁₀O₁₃P₂ (free acid) |
Pricing & Availability
Catalog Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
5.31889.0001 |
|
Glass bottle | 500 μg |
|
— |
References | |
---|---|
References | Wu, X., et al. 2014. Nuc. Aci. Res. 42, 8243. Zhang, X., et al. 2013. Mol. Cell. 51, 226. Wu, J., et al. 2013. Science. 339, 26. |
Product Information | |
---|---|
CAS number | 1441190-66-4 |
Form | White solid |
Hill Formula | C₂₀H₂₄N₁₀O₁₃P₂ (free acid) |
Chemical formula | C₂₀H₂₄N₁₀O₁₃P₂ (free acid) |
Hygroscopic | Hygroscopic |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | STING |
Primary Target K<sub>i</sub> | 4 nM, EC₅₀ |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalog Number | GTIN |
5.31889.0001 | 04055977260014 |
Documentation
STING Agonist, 2ʹ3ʹ-cGAMP - CAS 1441190-66-4 - Calbiochem SDS
Title |
---|
STING Agonist, 2ʹ3ʹ-cGAMP - CAS 1441190-66-4 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
531889 |
References
Reference overview |
---|
Wu, X., et al. 2014. Nuc. Aci. Res. 42, 8243. Zhang, X., et al. 2013. Mol. Cell. 51, 226. Wu, J., et al. 2013. Science. 339, 26. |
Brochure
Title |
---|
NPI Flyer- Epigenetics and Nuclear Function Feature |
New Products - Antibodies, Small Molecule, Inhibitors |
Technical Info
Title |
---|
White Paper: Further considerations of antibody validation and usage. |